tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
US Market

Kaken Pharmaceutical Co (KKPCF) Financial Statements

Compare
4 Followers

Kaken Pharmaceutical Co Financial Overview

Kaken Pharmaceutical Co's market cap is currently $948.55M. The company's EPS TTM is $-0.95297996; its P/E ratio is 11.11; and it has a dividend yield of 4.74%. Kaken Pharmaceutical Co is scheduled to report earnings on May 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 94.03B¥ 72.04B¥ 72.98B¥ 76.03B¥ 74.98B
Gross Profit¥ 58.26B¥ 38.54B¥ 39.56B¥ 41.58B¥ 40.91B
Operating Income¥ 21.04B¥ 9.51B¥ 8.00B¥ 17.06B¥ 17.79B
EBITDA¥ 22.02B¥ 12.57B¥ 10.57B¥ 16.38B¥ 20.11B
Net Income¥ 13.95B¥ 8.03B¥ 5.44B¥ 9.55B¥ 13.40B
Balance Sheet
Cash & Short-Term Investments¥ 70.08B¥ 65.32B¥ 74.26B¥ 74.62B¥ 77.31B
Total Assets¥ 190.42B¥ 171.62B¥ 166.33B¥ 165.18B¥ 163.33B
Total Debt¥ 3.85B¥ 3.85B¥ 3.85B¥ 3.85B¥ 3.85B
Net Debt¥ -50.24B¥ -46.77B¥ -55.71B¥ -57.17B¥ -59.86B
Total Liabilities¥ 37.78B¥ 27.87B¥ 29.49B¥ 26.86B¥ 27.08B
Stockholders' Equity¥ 152.63B¥ 143.75B¥ 136.26B¥ 137.75B¥ 136.26B
Cash Flow
Free Cash Flow¥ 25.64B¥ 410.00M¥ 7.05B¥ 10.08B¥ 12.09B
Operating Cash Flow¥ 29.78B¥ 2.58B¥ 9.25B¥ 13.34B¥ 14.38B
Investing Cash Flow¥ -19.65B¥ -5.85B¥ -2.63B¥ -7.89B¥ -1.64B
Financing Cash Flow¥ -5.37B¥ -5.66B¥ -6.99B¥ -8.13B¥ -8.75B
Currency in JPY

Kaken Pharmaceutical Co Earnings and Revenue History

Kaken Pharmaceutical Co Debt to Assets

Kaken Pharmaceutical Co Cash Flow

Kaken Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis